Effects of 2 wk of GH administration on 24-h indirect calorimetry in young, healthy, lean men. 2005

Mette Hansen, and Rikke Morthorst, and Benny Larsson, and Allan Flyvbjerg, and Michael Højby Rasmussen, and Hans Orskov, and Arne Astrup, and Michael Kjaer, and Kai Henrik Wiborg Lange
Institute of Sports Medicine, Copenhagen, Building 8, Bispebjerg Hospital, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark. mh19@bbh.hosp.dk

The present study was designed as a randomized, double-blind placebo (Plc)-controlled study to determine the effect of 2 wk of growth hormone administration (GH-adm.) on energy expenditure (EE) and substrate oxidation in healthy humans. Sixteen young healthy men were divided into two groups. The study consisted of two 24-h measurements (indirect calorimetry), separated by 2 wk of either Plc or GH injections (6 IU/day). At baseline, no significant differences were observed between the two groups in any of the measured anthropometric, hormonal, or metabolic parameters, neither did the parameters change over time in the Plc group. GH-adm. resulted in a 4.4% increase in 24-h EE (P < 0.05) and an increase in fat oxidation by 29% (P < 0.05). However, a decrease in the respiratory quotient was only observed in the postabsorptive phase after an overnight fast (0.84 +/- 0.1 to 0.79 +/- 0.1, P < 0.05). Furthermore, lean body mass (LBM) was increased by GH-adm. only [62.8 +/- 2.5 kg (baseline) vs. 64.7 +/- 2.4 kg (after), P < 0.001]. In conclusion, GH-adm. increases 24-h EE, which may be partly explained by increased LBM. Furthermore, GH-adm. stimulates fat combustion, especially in the postabsorptive state.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D010042 Ouabain A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE. Acocantherin,G-Strophanthin,Acolongifloroside K,G Strophanthin
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D002153 Calorimetry, Indirect Calculation of the energy expenditure in the form of heat production of the whole body or individual organs based on respiratory gas exchange. Calorimetry, Respiration,Calorimetries, Indirect,Calorimetries, Respiration,Indirect Calorimetries,Indirect Calorimetry,Respiration Calorimetries,Respiration Calorimetry
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005452 Fluoresceins A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays. Tetraiodofluorescein

Related Publications

Mette Hansen, and Rikke Morthorst, and Benny Larsson, and Allan Flyvbjerg, and Michael Højby Rasmussen, and Hans Orskov, and Arne Astrup, and Michael Kjaer, and Kai Henrik Wiborg Lange
February 1990, The American journal of clinical nutrition,
Mette Hansen, and Rikke Morthorst, and Benny Larsson, and Allan Flyvbjerg, and Michael Højby Rasmussen, and Hans Orskov, and Arne Astrup, and Michael Kjaer, and Kai Henrik Wiborg Lange
March 1980, The British journal of nutrition,
Mette Hansen, and Rikke Morthorst, and Benny Larsson, and Allan Flyvbjerg, and Michael Højby Rasmussen, and Hans Orskov, and Arne Astrup, and Michael Kjaer, and Kai Henrik Wiborg Lange
August 2012, Obesity (Silver Spring, Md.),
Mette Hansen, and Rikke Morthorst, and Benny Larsson, and Allan Flyvbjerg, and Michael Højby Rasmussen, and Hans Orskov, and Arne Astrup, and Michael Kjaer, and Kai Henrik Wiborg Lange
February 2018, Nutrition (Burbank, Los Angeles County, Calif.),
Mette Hansen, and Rikke Morthorst, and Benny Larsson, and Allan Flyvbjerg, and Michael Højby Rasmussen, and Hans Orskov, and Arne Astrup, and Michael Kjaer, and Kai Henrik Wiborg Lange
January 2022, Frontiers in neuroscience,
Mette Hansen, and Rikke Morthorst, and Benny Larsson, and Allan Flyvbjerg, and Michael Højby Rasmussen, and Hans Orskov, and Arne Astrup, and Michael Kjaer, and Kai Henrik Wiborg Lange
February 2013, The British journal of nutrition,
Mette Hansen, and Rikke Morthorst, and Benny Larsson, and Allan Flyvbjerg, and Michael Højby Rasmussen, and Hans Orskov, and Arne Astrup, and Michael Kjaer, and Kai Henrik Wiborg Lange
June 2016, Hypertension research : official journal of the Japanese Society of Hypertension,
Mette Hansen, and Rikke Morthorst, and Benny Larsson, and Allan Flyvbjerg, and Michael Højby Rasmussen, and Hans Orskov, and Arne Astrup, and Michael Kjaer, and Kai Henrik Wiborg Lange
November 1993, Clinical and experimental pharmacology & physiology,
Mette Hansen, and Rikke Morthorst, and Benny Larsson, and Allan Flyvbjerg, and Michael Højby Rasmussen, and Hans Orskov, and Arne Astrup, and Michael Kjaer, and Kai Henrik Wiborg Lange
July 1989, The Journal of endocrinology,
Mette Hansen, and Rikke Morthorst, and Benny Larsson, and Allan Flyvbjerg, and Michael Højby Rasmussen, and Hans Orskov, and Arne Astrup, and Michael Kjaer, and Kai Henrik Wiborg Lange
April 2002, Clinical endocrinology,
Copied contents to your clipboard!